Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Test Item | Analysis Specification | Result |
Description | White to almost white crystal | White to almost white crystal |
ldentification | A IR spectra shows the similarity between sample and standard B The retention time of the major peak corresponds with it of the reference standard |
Complies Complies |
Solution color and clearness | Colorless to pale-yellow clear solution | Complies |
Chlorides | Not more than 0.053% | <0.053% |
Sulphate | Not more than 0.011% | <0.011% |
Loss on drying | Not more than 1.5% | 0.66% |
Heavy metals | Not more than 0.002% | ≤0.002% |
Related Substances | TMP Not more than 0.15% Benzoic acid not more than0.1% Amide not more than 0.40% Single unknown impurity not more than0.1% Thiamine not more than0.1% Total impurities:Not more than 1.5% |
<0.025% No detectable 0.06% 0.08% No detectable 0.33% |
Residual solvents | Dichloromethane not more than 600ppm Isopropano not more than300ppm |
No detectable 64ppm |
Microbial limits | Total bacteria not more than100cfu/g Yeast and mould:not more than50cfu/g Escherichia coli:no detectable |
<10 cfu/g <10 cfu/g No detectable |
Assay(Dry Basis) | 98.0%~102.0% | 99.6% |
Conclusion | Complies with company Standard. |
1.It is used for the prevention and treatment of vitamin B1 deficiency;
2. For vitamin B1 demand increase, with inadequate intake from foods supplies (fatigue, hyperthyroidism, pregnancy, lactation, during strenuous manual labor, etc.);
3. Is used in the treatment of non alcoholic wernicke encephalopathy;
4. To treat beriberi;
5. Used in the following diseases, speculation and vitamin B1 deficiency and metabolic disorders associated with treatment, such as: neuralgia; Muscle pain, joint pain; Peripheral neuritis, peripheral nerve palsy; Myocardial metabolic disorders; Constipation and other gastrointestinal motor function obstacle.